DILUCA, MONICA MARIA GRAZIA
DILUCA, MONICA MARIA GRAZIA
Dipartimento di Scienze Farmacologiche e Biomolecolari
(+)-MCPG induces PKCε translocation in cortical synaptosomes through a PLD-coupled mGluR
2000 L. Pastorino, F. Colciaghi, F. Gardoni, S. Albani-Torregrossa, D.E. Pellegrini-Giampietro, F. Moroni, P.N.E. De Graan, F. Cattabeni, M.M.G. Di Luca
9. Congresso Sindem : Italian Association for the study of Dementia linked to the Italian Neurological Society (SIN)
2014 A. Padovani, A. Bruni, L. Pantoni, C. Caltagirone, L. Parnetti, F. Clerici, D. Perani, M.M.G. Diluca, S. Sorbi, G. Forloni, F. Tagliavini, G. Frisoni, M.G. Tempini, C. Mariani, A. Venneri, M. Musicco
A beta-induced deregulation of calcium homeostasis in glial cells in an innovative model of Alzheimer's disease
2011 A. Grolla, D. Lim, G. Balzaretti, G. Fakhfouri, E. Marcello, M.M.G. Diluca, P.L. Canonico, A.A. Genazzani
A combination of CSF tau ratio and midsaggital midbraintopons atrophy for the early diagnosis of progressive supranuclear palsy
2010 B. Borroni, M. Malinverno, F. Gardoni, M. Grassi, L. Parnetti, C. Agosti, A. Alberici, E. Premi, U. Bonuccelli, R. Gasparotti, P. Calabresi, M. Di Luca, A. Padovani
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia
2006 M. Malinverno, F. Gardoni, B. Picconi, V. Ghiglieri, F. Polli, V. Bagetta, G. Bernardi, F. Cattabeni, M. Di Luca, P. Calabresi
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia
2006 F. Gardoni, B. Picconi, V. Ghiglieri, F. Polli, V. Bagetta, G. Bernardi, F. Cattabeni, M. Diluca, P. Calabresi
A light-gated potassium channel for sustained neuronal inhibition
2018 L. Alberio, A. Locarno, A. Saponaro, E. Romano, V. Bercier, S. Albadri, F. Simeoni, S. Moleri, S. Pelucchi, A. Porro, E. Marcello, N. Barsotti, K. Kukovetz, A.J. Boender, A. Contestabile, S. Luo, A. Moutal, Y. Ji, G. Romani, M. Beltrame, F. Del Bene, M. Di Luca, R. Khanna, H.M. Colecraft, M. Pasqualetti, G. Thiel, R. Tonini, A. Moroni
A novel splicing form of BACE (BACEdelta7) is lacking in cells of Alzheimer's disease patients: a novel approach to pathogenesis
2002 F. Colciaghi, E. Marcello, M. Zimmermann, F. Cattabeni, M.M. G DiLuca, B. Borroni, E. Del Zotto, A. Padovani
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism
2004 B. Picconi, F. Gardoni , D. Centonze, D. Mauceri, M.A. Cenci, G. Bernardi, P. Calabresi, M. Di Luca
Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome
1996 M. DiLuca, L. Pastorino, F. Cattabeni, R. Zanardi, S. Scarone, G. Racagni, E. Smeraldi, J. Perez
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease
2002 A. Padovani, B. Borroni, F. Colciaghi, C. Pettenati, E. Cottini, C. Agosti, G.L. Lenzi, C. Caltagirone, M. Trabucchi, F. Cattabeni, M.M.G. Di Luca
Abnormalities of amyloid β precursor protein expression in platelets of patients with Alzheimer disease: Do we understand them well enough?
1999 I. Blasko, F. Marx, B. Grubeck-Loebenstein, J. Marksteiner, M.M.G. Di Luca, L. Pastorino, F. Colciaghi, F. Cattabeni, A. Padovani
Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines
2004 M. Zimmermann, F. Gardoni, E. Marcello, F. Colciaghi, B. Borroni, A. Padovani, F. Cattabeni, M. Di Luca
ADAM10 as a therapeutic target for brain diseases : from developmental disorders to Alzheimer's disease
2017 E. Marcello, B. Borroni, S. Pelucchi, F. Gardoni, M. Di Luca
ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects
2015 P.R. Manzine, E. Marcello, B. Borroni, W. Kamphuis, E. Hol, A. Padovani, C.C. Nascimento, P. De Godoy Bueno, F. Assis Carvalho Vale, S.C. Iost Pavarini, M. Di Luca, M.R. Cominetti
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
2019 P.R. Manzine, M. Ettcheto, A. Cano, O. Busquets, E. Marcello, S. Pelucchi, M. Di Luca, K. Endres, J. Olloquequi, A. Camins, M.R. Cominetti
ADAM10 in Synaptic Physiology and Pathology
2014 S. Musardo, E. Marcello, F. Gardoni, M. Di Luca
ADAM10 inhibition to treat Fragile X syndrome
2015 C. Bagni, E. Pasciuto, M.M.G. Diluca, E. Marcello, F. Gardoni
Adam10 plasma and csf levels are increased in mild Alzheimer’s disease
2021 I.P. Vanatabe, R. Peron, M.M. Grigoli, S. Pelucchi, G. De Cesare, T. Magalhaes, P.R. Manzine, M.L.F. Balthazar, M. Di Luca, E. Marcello, M.R. Cominetti
ADAM10 regulates dendritic spine morphology and glutamate receptor composition trough N-Cadherin cleavage
2009 M. Malinverrno, F. Gardoni, M. Carta, C. Sala, C. Mulle, F. Cattabeni, M. Di Luca, M. Malinverno